4//SEC Filing
Tourangeau Greg 4
Accession 0000899243-22-017416
CIK 0001680581other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:15 PM ET
Size
7.6 KB
Accession
0000899243-22-017416
Insider Transaction Report
Form 4
Tourangeau Greg
Principal Accounting Officer
Transactions
- Award
Common Stock
2022-05-06+3,250→ 16,202 total - Award
Stock Option (right to buy)
2022-05-06+6,500→ 6,500 totalExercise: $8.63Exp: 2032-05-05→ Common Stock (6,500 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock unit (RSU) awards granted on May 6, 2022, with each RSU representing a right to receive one share of common stock. The RSU is subject to time-based vesting with (i) 25% of the shares vesting on May 6, 2023, (ii) 25% of the shares vesting on May 6, 2024, and (iii) 50% of the shares vesting on May 6, 2025, subject to the reporting person's continued service on each such vesting date.
- [F2]This option was granted on May 6, 2022 and is subject to time-based vesting, with (i) 25% of the options vesting on May 6, 2023, (ii) 25% of the options vesting on May 6, 2024, and (iii) 50% of the options vesting on May 6, 2025, subject to the reporting person's continued service on each such vesting date.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001916566
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 4:15 PM ET
- Size
- 7.6 KB